Literature DB >> 17547832

The new diabetes inhalers: new tools for the clinician.

William T Cefalu1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17547832     DOI: 10.1007/s11892-007-0026-2

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


× No keyword cloud information.
  19 in total

Review 1.  Poor glycaemic control in type 2 diabetes: a conspiracy of disease, suboptimal therapy and attitude.

Authors:  T M Wallace; D R Matthews
Journal:  QJM       Date:  2000-06

Review 2.  Novel routes of insulin delivery for patients with type 1 or type 2 diabetes.

Authors:  W T Cefalu
Journal:  Ann Med       Date:  2001-12       Impact factor: 4.709

Review 3.  Alternative delivery routes: inhaled insulin.

Authors:  L Heinemann
Journal:  Diabetes Nutr Metab       Date:  2002-12

4.  Novel insulins and strict glycemic control. Analogues approximate normal insulin secretory response.

Authors:  John R White; R Keith Campbell; Irl B Hirsch
Journal:  Postgrad Med       Date:  2003-06       Impact factor: 3.840

Review 5.  Glucagon-like peptide-1: from extract to agent. The Claude Bernard Lecture, 2005.

Authors:  J J Holst
Journal:  Diabetologia       Date:  2006-01-14       Impact factor: 10.122

6.  Injection related anxiety in insulin-treated diabetes.

Authors:  A Zambanini; R B Newson; M Maisey; M D Feher
Journal:  Diabetes Res Clin Pract       Date:  1999-12       Impact factor: 5.602

7.  Efficacy and safety of preprandial human insulin inhalation powder versus injectable insulin in patients with type 1 diabetes.

Authors:  S Garg; J Rosenstock; B L Silverman; B Sun; C S Konkoy; A de la Peña; D B Muchmore
Journal:  Diabetologia       Date:  2006-02-28       Impact factor: 10.122

8.  Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial.

Authors:  Teresa Quattrin; André Bélanger; Nancy J V Bohannon; Sherwyn L Schwartz
Journal:  Diabetes Care       Date:  2004-11       Impact factor: 19.112

9.  Efficacy and safety of inhaled insulin (exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: results of a 6-month, randomized, comparative trial.

Authors:  Priscilla A Hollander; Lawrence Blonde; Richard Rowe; Adi E Mehta; Joseph L Milburn; Kenneth S Hershon; Jean-Louis Chiasson; Seymour R Levin
Journal:  Diabetes Care       Date:  2004-10       Impact factor: 19.112

10.  Patient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetes.

Authors:  Julio Rosenstock; Joseph C Cappelleri; Björn Bolinder; Robert A Gerber
Journal:  Diabetes Care       Date:  2004-06       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.